NADOLOL
- Product NDC
- 50742-180
- 11-digit product format
- 507420180
- Labeler code
- 50742
- Product ID
- 50742-180_adaa61d0-cc7f-4a1c-b978-c45e8977b6be
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- nadolol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Ingenus Pharmaceuticals, LLC
- Application
- ANDA210786
- Marketing category
- ANDA
- Marketing start
- 2018-06-08
- Marketing end
- 0000-00-00
- Substance
- NADOLOL
- Active strength
- 80 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50742-180-01 | 50742018001 | 100 TABLET in 1 BOTTLE (50742-180-01) | 100 tablet | 2018-06-08 | 0000-00-00 | No | No | Current |
| 50742-180-10 | 50742018010 | 1000 TABLET in 1 BOTTLE (50742-180-10) | 1000 tablet | 2018-06-08 | 0000-00-00 | No | No | Current |